Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Director/PDMR Shareholding

15 May 2024 15:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 13 May 2024, Pascal Soriot, Chief Executive Officer, was granted an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) under the terms of the AstraZeneca Performance Share Plan (AZPSP), as detailed in the table below. This award forms part of the AZPSP award granted to Mr Soriot on 4 March 2024. As described in AstraZeneca's 2023 Directors' Remuneration Report, it has been made in accordance with the Directors' Remuneration Policy

BoMill announces outcome of the wholly guaranteed Rights Issue

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER ACTIONS. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" BELOW. BoMill AB (the "Company" or "BoMill") announces hereby the outcome of the wholly guaranteed rights issue of shares with a subscription

Resolutions of Mandatum plc’s Annual General Meeting and Board of Directors’ organisational meeting

Mandatum plc, stock exchange release, 15 May 2024 at 4.45 p.m. EEST   The Annual General Meeting of Mandatum plc held on 15 May 2024 (hereinafter, the "AGM") approved all proposals made to the AGM by the Shareholders’ Nomination Board and the Board of Directors, including distribution of dividend of EUR 0.33 per share. The AGM adopted the financial statements for the financial year 2023 and discharged the members of the Board of Directors and the CEO from liability for the financial period ending 31 December 2023. The AGM authorised the Board of Directors to resolve on the

Eevia Health Plc exhibiting at an essential Nutraceutical tradeshow

Eevia Health Plc (”Eevia” or ”The Company”) is promoting its products and value proposition by exhibiting at Vitafoods 2024, an essential nutraceutical tradeshow held in Geneva, Switzerland, between 14 – 16 May 2023.This week, Eevia is at the annual Vitafoods Nutraceuticals tradeshow in Geneva. Vitafoods is a key event in the global nutraceutical industry, attracting over 16,000 industry experts from over 130 countries every year. The show has a leading position in the industry by maintaining a strong focus and high quality, including an extensive seminar

Bulletin from Annual General Meeting in Paradox Interactive AB (publ) held on 15 May 2024

The Annual General Meeting (the “AGM”) of Paradox Interactive AB (publ) was held today. The AGM was carried out through advance voting (postal voting) as well as physical attendance of shareholders. Financial statements and dividend The AGM adopted the income statement and the balance sheet as well as the group income statement and the group balance sheet for the 2023 financial year. The AGM resolved on dividend to the shareholders of SEK 3,00 per share in accordance with the proposal of the board of directors, with 17 May 2024 as record date for dividends. Payment of the dividend is

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (14 May 2024)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 May 2024 at 16:30 EESTStora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 15 May 2024. On 14 May 2024, BlackRock's total holding, including holding through financial instruments, in Stora Enso’s shares increased above the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial instruments|in % (7.A

ees 2024: Flexible Home Storage System Power4Home from BMZ with up to 106.8 kWh Capacity

BMZ Group presents innovative energy storage systems for private and industrial usePress Release Karlstein am Main, May 21, 2024 – The BMZ Group, a global specialist for lithium-ion and sodium-ion battery systems, is presenting its latest iteration of the Power4Home home storage system at ees Europe (June 19–21, 2024, Messe Munich, indoor stand C2.360, outdoor stand FM.605/15). As an innovative power supply system for the home, Power4Home sets new standards and offers maximum flexibility. Power4Home can be wall- or floor-mounted indoors as well as outdoors. Thanks to its slim profile of

Bulletin from the 2024 Annual General Meeting of Catena Media plc

The Annual General Meeting of Catena Media plc (the "Company") was held at Hilton Malta, Portomaso, St. Julian's, STJ4012, Malta on Wednesday, 15 May 2024 (the “Meeting”). The below is a summary of the salient parts of the Meeting. It was resolved to approve the Consolidated Financial Statements of the Company, the Director’s Report and the Auditor’s Report for the financial year ending 31 December 2023. The Meeting resolved not to declare any dividends for the financial year of 2023, in accordance with the proposal from the Board of Directors. The Meeting resolved that the Board

NIB continues to finance healthcare services in North Savo, Finland

The Nordic Investment Bank (NIB) and the Wellbeing Services County (WSC) of North Savo have agreed an uncommitted credit facility of EUR 100 million. The 20-year loan facility is earmarked for the renovation and construction of hospital buildings in Kuopio, Finland. The loan agreement is the second between NIB and the North Savo WSC. The hospital infrastructure managed by the North Savo WSC is undergoing a transformation, with outdated facilities being modernised to meet modern healthcare needs. “Investments in healthcare services are crucial for higher service capacity, more

ExpreS2ion to present in spring investor events

Hørsholm, Denmark, 15 May 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor events.By attending relevant industry and investor events, the company aims to increase the awareness of its technology platform and its exciting development pipeline. More information on each event and how to register is found below and on the Company’s website . 16 May 2024 | First quarter 2024 financial results webcast, hosted by HC Andersen Capital10:00 CET | VirtualExpreS2ion CEO

Notice of Extraordinary General Meeting 2024 of Catena Media plc.

NOTICE OF EXTRAORDINARY GENERAL MEETING 2024 OF CATENA MEDIA PLC in accordance with Articles 18 and 19 of the Articles of Association of the Company (the “Articles”). NOTICE IS HEREBY GIVEN that the EXTRAORDINARY GENERAL MEETING (the “Meeting”) of Catena Media plc, company registration number C70858 (the “Company” or “Catena”), will be held on Wednesday, 17 July 2024, at 08:00 (UTC) (10:00 (CEST)) at Catena Media, Quantum Place, Triq ix-Xatt Ta' Xbiex, Gzira, Malta GZR 1052. The registration of shareholders starts at 09:00 (CEST). Purpose of the Meeting · At the Company's

Redsense Medical presents at Sedermeradagen Stockholm 2024

Sedermera Corporate Finance will once again host Sedermeradagen on May 22, 2024. The event will take place at Hotel At Six in Stockholm and offers the opportunity to get to know 16 highly interesting growth companies. Redsense Medical CEO Pontus Nobréus will present the company. The presentation will be held in Swedish. To register and for more information about the event: Sedermeradagen Stockholm 2024 - Sedermera Corporate Finance 

Interim Report January – March 2024

Best quarter for enzyme business in analytics and stronger cash position January – March 2024 · Net sales totaled SEK 40,057 (71,276) thousand, with a growth rate of -44%. Adjusted for currency effects, the decrease is -44%. Organic growth adjusted for license revenue is 0.4%, and 0.5% when also adjusted for currency effects.  · Operating profit before depreciation and amortization (EBITDA) totaled SEK 18,568 (45,089) thousand. Adjusted for license revenue and related costs, EBITDA is SEK 8,440 (6,223) thousand. · Operating profit (EBIT) totaled SEK 15,833 (43,399) thousand.

Heart Aerospace Appoints Benjamin Stabler as Chief Technology Officer

Heart Aerospace, a leading hybrid-electric airplane maker, proudly announces the appointment of Benjamin Stabler as its new Chief Technology Officer, effective immediately. The appointment comes as Heart Aerospace, based in Sweden, enters a new phase of hardware testing in advance of the company demonstrating fully electric flight during next year.Stabler brings a wealth of experience and expertise to Heart Aerospace, having led hardware and software teams on the Crew Dragon program at SpaceX and served as co-founder of Parallel Systems, developer of automated, battery-electric freight rail

Electronic music pioneer Richie Hawtin Partners with Epidemic Sound to Mentor the Next Generation of Artists and Global Music Talent

· Today, Epidemic Sound announces its partnership with renowned DJ, producer, and electronic music pioneer Richie Hawtin  · Hawtin will mentor four innovative, up-and-coming Epidemic Sound artists, offering feedback on their tracks, as well as guidance on their music careers, artistic development, and release tactics · Richie Hawtin and Epidemic Sound’s shared roles as innovators in the music industry make this partnership a perfect fit to push boundaries for the betterment of emerging modern artists Stockholm, Sweden – Epidemic Sound , the

Heart Aerospace opens US R&D hub, enters new development phase for hybrid-electric airplane

Swedish hybrid-electric airplane maker, Heart Aerospace, announces a significant milestone with the opening of a new Research and Development hub in the United States. This strategic move comes as the company prepares to enter a new phase of hardware testing in the development of its first regional hybrid-electric airplane, the ES-30.The Los Angeles-based R&D hub will focus on the advancement of Heart’s hybrid-electric propulsion system and other key technologies. The company will relocate its full-scale aircraft demonstrator to the US, where it aims to demonstrate proof of concept of a new

TactoTek Licenses IMSE® Technology to Polestar for Sustainable Electronics Design Innovation

· TactoTek and Polestar have entered a collaboration to explore how Injection Molded Structural Electronics (IMSE[®]) solutions can be integrated in the design of Polestar's vehicles, creating more sustainable, lightweight, advanced electronic features for their customers. · IMSE technology supports innovative interior and exterior lighting solutions plus modern human-machine interfaces, in lightweight, single piece structures. · Re-imagining vehicles and their systems at design time enables step-function sustainability improvements.15 May 2024 – Oulu, Finland and Gothenburg, Sweden –

Annual General Meeting in Bong AB

Bong AB has today, 15 May 2024, held the annual general meeting at Mangold Fondkommission AB at Nybrogatan 55 in Stockholm.The following resolutions were resolved by the annual general meeting. · The annual general meeting adopted the annual and consolidated accounts and resolved that no dividend shall be paid, and that the results should be carried forward. · The annual general meeting resolved to discharge the board of directors and the CEO from liability. · The annual general meeting resolved, in accordance with the nomination committee´s proposal, that the board shall consist

Report from Annual General Meeting in Intervacc

Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 15 May 2024, at which the following resolutions were made. Adoption of the income statement and balance sheet The AGM adopted the Board of Directors’ submitted income statement and balance sheet for the parent company and the group for the financial year 2023. Appropriation of the company’s profit or loss The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for the financial year 2023, and that the result shall be balanced in a new account. Discharge

Important milestones in sustainability work 2023

The environment lies at the core of Kiilto’s sustainability actions. As a chemical industry company, Kiilto is in a prime position to have an impact on environmental responsibility issues in particular. Our Promise to the Environment, which we launched in 2018, has been guiding our sustainability work and communications ever since. 2023 included successes, innovations and lessons we learned from.Advancing in Our Promise to the Environment targets Our Promise to the Environment  consists of four areas that cover

Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture

Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.The Tamer Mölnlycke Care joint venture was initiated in 2021 with the agreement to develop a customised surgical procedure tray factory in Saudi Arabia, with first production expected in Q4 2024.   The increased investment allows for an expansion in the range of

Calliditas Therapeutics to Present Data at ERA 2024 May 23 – 26 in Stockholm

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”), today announced upcoming data presentations and a sponsored symposium at the 61[st] European Renal Association (ERA) Congress, in Stockholm, Sweden on May 23 – 26, 2024.Data presentations will include an efficacy analysis of Nefecon (TARPEYO® (budesonide) delayed release capsules)) in primary immunoglobulin A nephropathy (IgAN) as well as a real-world analysis of the challenges associated with the use of systemic glucocorticoids (SGC) in IgAN. “We are delighted to participate in ERA and look forward to

Catena upgraded to ”BBB” by Nordic Credit Rating

Nordic Credit Rating (NCR) has upgraded its long-term credit rating on Catena to BBB from BBB-. The outlook is stable.15 May 2024, 2.00 p.m. CESTThe new rating reflects Catena’s strong position as one of Sweden’s largest logistics property company and Catena’s gradual shift in financial leverage during the last years. - We are pleased that NCR decides to raise Catena’s credit rating. Our targeted work has strengthened the company both operationally and financially, which the rating confirms. That gives us the opportunity to stay vigorous for continued expansion, comments David Silvesjö,

There are no items matching the current filter
There are no more items matching the current filter
Back to top